Cover Image

Effects of vitamin K antagonist phenprocoumon on activated partial thromboplastin time measurement of direct thrombin inhibitors

The activated partial thromboplastin time (aPTT) is currently the most common test used to measure the anticoagulation intensity of heparins and direct thrombin inhibitors (DTIs). Vitamin K antagonists variably affect aPTT reagents. Interactions between heparin and DTIs occur during concurrent thera...

Full description

Saved in:
Bibliographic Details
Main Authors: Fenyvesi, Tivadar (Author) , Jörg, Ingrid (Author) , Weiß, Christel (Author) , Harenberg, Job (Author)
Format: Article (Journal)
Language:English
Published: 2004
In: Blood coagulation & fibrinolysis
Year: 2004, Volume: 15, Issue: 7, Pages: 605-611
ISSN:1473-5733
DOI:10.1097/00001721-200410000-00012
Online Access:Verlag, lizenzpflichtig, Volltext: https://journals.lww.com/bloodcoagulation/Fulltext/2004/10000/Effects_of_vitamin_K_antagonist_phenprocoumon_on.12.aspx
Verlag: https://dx.doi.org/10.1097/00001721-200410000-00012
Get full text
Author Notes:Tivadar Fenyvesi, Ingrid Jörg, Christel Weiss, Job Harenberg
Description
Summary:The activated partial thromboplastin time (aPTT) is currently the most common test used to measure the anticoagulation intensity of heparins and direct thrombin inhibitors (DTIs). Vitamin K antagonists variably affect aPTT reagents. Interactions between heparin and DTIs occur during concurrent therapy. Three DTIs (lepirudin, argatroban, melagatran) and one unfractionated heparin (liquemin) were added to normal plasma (NP) samples (n = 23) and to vitamin K antagonist plasma (VKAP) samples (n = 23) of patients treated with phenprocoumon. Lepirudin and argatroban were added at concentrations from 300 to 3000 ng/ml, melagatran from 30 to 1000 ng/ml, and unfractionated heparin from 0.016 to 0.48 IU/ml. Wave parameters of clotting time and aPTT ratio curves were evaluated by multivariate analysis for inhibitors, aPTT reagents and NP and VKAP samples. Normal ranges resulting from NP samples were 34.5 ± 1.0 s with Pathromtin SL and 33.9 ± 0.8 s with Platelin LS. Normal ranges using VKAP were 52.8 ± 2.6 s (Pathromtin SL) and 44.2 ± 1.1 s (Platelin LS) (P < 0.0001). Variance analysis showed that inhibitors, plasmas (NP versus VKAP) and reagents influenced the wave characteristics of aPTT (s) (P< 0.0001) and aPTT ratios (P< 0.0001). Distinct statistical differences between aPTT reagents on one hand and normal versus vitamin K antagonist plasma on the other hand make a comparison of reported aPTT results difficult, especially during overlapping therapy with vitamin K antagonists.
Item Description:Gesehen am 21.04.2022
Physical Description:Online Resource
ISSN:1473-5733
DOI:10.1097/00001721-200410000-00012

Similar Items